Anthem Biosciences IPO GMP Surges to 27% Ahead of Listing– Subscription & Allotment Details Inside!
Anthem Biosciences IPO: Anthem Biosciences IPO has made headlines this week with blockbuster oversubscription across all investor categories. The biotech-based CRDMO firm witnessed huge investor enthusiasm, with the issue being subscribed 63.86 times, led by QIBs bidding 182.65 times. With the IPO allotment status expected today, investors are keen to know whether they’ve hit the...